跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Immunorel - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Immunorel
Approved
STANDARD
Immunorel
Reliance Life Sciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9b4e47e03f294e1c
Company
Reliance Life Sciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
9b4e47e03f294e1c
Drug Approval Philippines Name
Immunorel
Product Name
Immunorel
Registration Number
BRP-052
Brand Name
Immunorel
Generic Name
Human Normal Immunoglobulin
Dosage Form
Solution for Infusion IV
Dosage Strength
5% (50 mg/mL)
Manufacturer
Reliance Life Sciences Pvt. Ltd.
Importer
Ambica International Corp.
Distributor
Ambica International Corp.
Issuance Date
24 May 2019
Expiry Date
07 March 2029
Pharmacologic Category
Immunoglobulin
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9b4e47e03f294e1c
Type
Standard
Back to Philippines FDA Approvals